Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Total article views   HTML views PDF downloads Totals
6,730 Dovepress* 5,305+ 117 5,422
PubMed Central* 1,425 260 1,685
Totals 6,730 377 7,107
*Since 3 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar